Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapy

Lab on a Chip
Han Wei HouJongyoon Han

Abstract

Sepsis represents a systemic inflammatory response caused by microbial infection in blood. Herein, we present a novel comprehensive approach to mitigate inflammatory responses through broad spectrum removal of pathogens, leukocytes and cytokines based on biomimetic cell margination. Using a murine model of polymicrobial sepsis induced by cecal ligation and puncture (CLP), we performed extracorporeal blood filtration with the developed microfluidic blood margination (μBM) device. Circulating bacteremia, leukocytes and cytokines in blood decreased post-filtration and significant attenuation of immune cell and cytokine responses were observed 3-5 days after intervention, indicating successful long-term immunomodulation. A dose-dependent effect on long-term immune cell count was also achieved by varying filtration time. As proof of concept for human therapy, the μBM device was scaled up to achieve ∼100-fold higher throughput (∼150 mL h(-1)). With further multiplexing, the μBM technique could be applied in clinical settings as an adjunctive treatment for sepsis and other inflammatory diseases.

References

Nov 1, 1989·The American Journal of Physiology·A J Moe, C H Smith
Nov 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P A AartsR M Heethaar
Mar 1, 1984·Microvascular Research·H L Goldsmith, S Spain
Aug 1, 1980·The Journal of Surgical Research·K A WichtermanI H Chaudry
Jul 1, 1995·Critical Care Medicine·R Lefering, E A Neugebauer
Mar 9, 2000·Critical Care Medicine·A C MavrommatisS Zakynthinos
Sep 16, 2000·Intensive Care Medicine·A C Muller KoboldJ W Tervaert
Aug 11, 2001·Intensive Care Medicine·L ColeP Tipping
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Dec 20, 2002·Nature·Jonathan Cohen
Jan 10, 2003·The New England Journal of Medicine·Richard S Hotchkiss, Irene E Karl
Feb 1, 2005·Analytical Chemistry·Sergey S ShevkoplyasMark W Bitensky
Jul 1, 2005·Shock·Laszlo M HoeselPeter A Ward
Oct 15, 2005·Nature Reviews. Drug Discovery·Jon A BurasMichail Sitkovsky
Jul 11, 2006·Lancet·K A BrownD F Treacher
Aug 24, 2006·Infection and Immunity·Hongyan XiaoDaniel G Remick
Sep 28, 2006·Biomedical Microdevices·Nan XiaDonald E Ingber
Nov 23, 2007·Journal of Leukocyte Biology·Marcel SchoutenTom van der Poll
Apr 25, 2008·Critical Care Medicine·Zhi-Yong PengJohn A Kellum
Dec 31, 2008·Critical Care Medicine·Martin SauerSteffen R Mitzner
Apr 17, 2009·Lab on a Chip·Chong Wing YungDonald E Ingber
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Djillali AnnaneG Umberto Meduri
Jun 18, 2009·JAMA : the Journal of the American Medical Association·Dinna N CruzClaudio Ronco
Sep 22, 2009·PloS One·Abhishek Jain, Lance L Munn
Feb 2, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Matthieu LegrandCan Ince
Aug 31, 2010·Nature Medicine·Kenneth T KotzUNKNOWN Inflammation and the Host Response to Injury Collaborative Research Program
Oct 20, 2010·Expert Review of Anti-infective Therapy·Guillaume Monneret, Fabienne Venet
Feb 18, 2011·The New England Journal of Medicine·Holger K Eltzschig, Peter Carmeliet
Mar 5, 2011·Critical Care : the Official Journal of the Critical Care Forum·Jens AltrichterSteffen R Mitzner
Jul 26, 2011·Nature Reviews. Immunology·Alberto MantovaniSébastien Jaillon
Oct 28, 2011·Expert Review of Anti-infective Therapy·Eirini ChristakiSteven M Opal
Mar 14, 2012·PLoS Computational Biology·Sang Ok SongGilles Clermont
May 24, 2012·The New England Journal of Medicine·V Marco RanieriUNKNOWN PROWESS-SHOCK Study Group
Jun 30, 2012·The Lancet Infectious Diseases·Jonathan CohenThierry Calandra
Aug 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Driss El KebirJános G Filep
Mar 28, 2013·Critical Care : the Official Journal of the Critical Care Forum·Thomas RimmeléJohn A Kellum
Jul 6, 2014·Critical Care : the Official Journal of the Critical Care Forum·Zhi-Yong PengJohn A Kellum
Sep 14, 2014·Nature Medicine·Joo H KangDonald E Ingber

❮ Previous
Next ❯

Citations

Apr 4, 2017·Colloids and Surfaces. B, Biointerfaces·Mahsa AlizadehWilliam G Pitt
Nov 2, 2016·Lab on a Chip·Javier L PrietoJoel Voldman
Feb 7, 2019·Lab on a Chip·Taylor OeschgerDavid Erickson
May 11, 2016·Biotechnology Progress·William G PittAlex K Hunter
Mar 27, 2018·Biomicrofluidics·Yuanyuan ChenHaosheng Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.